BioLife Solutions, Inc.
BLFS
$15.86
$0.724.76%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 32.73M | 33.33M | 39.51M | 37.70M | 44.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.73M | 33.33M | 39.51M | 37.70M | 44.26M |
| Cost of Revenue | 23.48M | 21.68M | 27.70M | 23.66M | 30.04M |
| Gross Profit | 9.25M | 11.65M | 11.81M | 14.04M | 14.22M |
| SG&A Expenses | 17.51M | 19.77M | 21.72M | 21.31M | 18.54M |
| Depreciation & Amortization | 915.00K | 1.36M | 1.45M | 1.46M | 1.46M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.30M | 48.21M | 55.71M | 50.59M | 54.20M |
| Operating Income | -13.57M | -14.88M | -16.20M | -12.89M | -9.94M |
| Income Before Tax | -13.43M | -29.02M | -10.19M | -13.62M | -49.27M |
| Income Tax Expenses | -43.00K | 115.00K | 5.00K | 92.00K | -85.00K |
| Earnings from Continuing Operations | -13.38M | -29.13M | -10.20M | -13.71M | -49.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.38M | -29.13M | -10.20M | -13.71M | -49.19M |
| EBIT | -13.57M | -14.88M | -16.20M | -12.89M | -9.94M |
| EBITDA | -11.19M | -11.60M | -12.74M | -9.71M | -6.76M |
| EPS Basic | -0.30 | -0.67 | -0.23 | -0.32 | -1.15 |
| Normalized Basic EPS | -0.19 | -0.22 | -0.23 | -0.19 | -0.15 |
| EPS Diluted | -0.30 | -0.67 | -0.23 | -0.32 | -1.15 |
| Normalized Diluted EPS | -0.19 | -0.22 | -0.23 | -0.19 | -0.15 |
| Average Basic Shares Outstanding | 44.82M | 43.57M | 43.44M | 43.03M | 42.79M |
| Average Diluted Shares Outstanding | 44.82M | 43.57M | 43.44M | 43.03M | 42.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
